Datasets:

Suchinthana
/

support2-1

Dataset card Viewer Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
8,701	79.65198	0	female	0	8	817	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	20,446	13,634.6875	13,886.8672	20.5	white	23.199219	46	0.721924	0.635986	5	1	0	no	null	null	no dnr	8	111	null	74	12	35.69531	293.3125	null	null	2	137	7.65918	114	46	null	null	0	no(M2 and SIP pres)	0
8,702	76.79395	1	male	0	9	473	COPD	COPD/CHF/Cirrhosis	2	null	null	0	6,728	4,467.4805	4,173.90625	8	white	21.5	29	0.781982	0.650879	1	0	0	no	0.95	0.9	dnr after sadm	2	82	3.799805	77	20	36.29688	null	4.199219	0.699951	1.099854	138	null	138	18	5,150	null	null	null	3.375977
8,703	85.88898	1	female	0	7	15	Coma	Coma	0	16	$11-$25k	89	34,805	24,401.1719	25,418.6875	22.5	white	20.898438	28	0.077988	0.043999	12	0	0	no	0.02	0	dnr after sadm	3	66	8.298828	56	28	36	221.71875	4.299805	1.099854	0.899902	137	7.329102	168	15	1,700	null	0	<2 mo. follow-up	0
8,704	35.15399	0	male	0	22	811	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	94	100,043	66,069.8125	63,446.2812	32.666657	white	16.199219	37	0.716919	0.630981	12	0	0	no	0.8	0.75	no dnr	22	126	14.199219	132	10	39.29688	154	2.199707	1.899902	1	135	7.389648	235	17	2,785	null	0	adl>=4 (>=5 if sur)	0
8,705	46.57599	0	female	0	37	811	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	100,646	68,337.125	66,688.625	35	white	39.5	60	0.588989	0.47998	1	0	0	no	0.9	0.9	no dnr	37	43	10.599609	0	0	38.39844	133.3125	null	1.399902	2.5	132	7.379883	345	38	1,300	null	null	null	2.007813
8,706	68.38898	0	female	0	15	808	COPD	COPD/CHF/Cirrhosis	5	11	null	0	26,261	17,221.2969	17,921.8438	11.666664	white	17.296875	17	0.846924	0.747925	1	0	0	yes	1	1	no dnr	15	78	7	83	20	35.89844	323.75	3.899902	0.899902	1.899902	143	7.519531	95	39	1,975	1	0	no(M2 and SIP pres)	0
8,707	78.29999	1	male	1	154	154	COPD	COPD/CHF/Cirrhosis	1	null	null	0	245,741	169,825.875	192,487.5	24.25	white	32.695313	39	0.522949	0.322998	1	0	0	no	0.8	0.6	dnr after sadm	133	70	5.899414	54	22	35.89844	295.1875	null	null	2.099609	143	7.419922	98	48	1,700	null	1	Coma or Intub	1
8,708	73.89697	1	female	1	42	42	COPD	COPD/CHF/Cirrhosis	1	10	under $11k	44	84,535	57,884.5625	64,970.9688	28.75	white	27	35	0.519897	0.319946	1	0	0	no	0.5	0.5	dnr after sadm	40	53	null	105	10	38.79688	87.04688	2.899902	1.399902	2.799805	132	7.5	169	68	1,898	null	1	<2 mo. follow-up	1
8,709	38.90799	0	female	0	22	808	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	46,452	32,660.1562	37,199.125	22	white	28	47	0.795898	0.728882	1	1	0	yes	0.75	0.75	no dnr	22	81	10.099609	74	22	35.79688	null	3.599609	2.899902	1.099854	125	null	111	9	null	null	1	null	1
8,710	78.18994	1	male	0	3	126	CHF	COPD/CHF/Cirrhosis	2	null	null	0	2,297	1,613.8281	1,369.46973	null	white	19.296875	22	0.828979	0.720947	1	0	0	no	0.5	0.2	no dnr	3	122	8.199219	87	24	35.89844	133.3125	4.599609	0.599976	0.699951	142	7.339844	113	11	null	null	null	null	2.075684
8,711	32.13397	0	male	0	11	803	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	null	0	9,885	6,642.668	6,093.61719	13	white	14.199219	21	0.949951	0.930908	1	1	0	no	0.99	0.99	no dnr	11	119	11.599609	67	16	36.09375	null	2.299805	0.399963	1.799805	137	null	240	26	1,425	1	1	null	1
8,712	38.25098	0	male	0	33	804	Cirrhosis	COPD/CHF/Cirrhosis	2	12	null	0	47,539	31,000.7188	33,095.0312	8.25	white	23.699219	43	0.8479	0.750977	1	0	0	no	0.95	0.95	no dnr	33	111	8.699219	122	24	37.89844	252.375	null	0.399963	1.5	134	7.429688	124	20	2,000	null	null	no(M2 and SIP pres)	2.790527
8,713	56.46298	1	male	0	3	142	Lung Cancer	Cancer	1	12	null	0	3,338	2,026.9092	1,108.2793	null	white	14	5	0.778931	0.53894	1	0	0	metastatic	0.9	0.6	no dnr	3	63	3.299805	130	9	39.29688	155	2.699707	2.299805	0.799927	133	7.419922	94	9	5,025	null	null	null	1.932861
8,714	63.24197	0	female	0	8	801	COPD	COPD/CHF/Cirrhosis	7	12	null	0	6,430	4,216.7852	3,579.25977	9.5	white	27.398438	42	0.778931	0.645996	1	1	0	no	1	1	no dnr	8	72	null	53	22	36.19531	null	null	null	1	137	null	90	17	2,250	0	1	no(M2 and SIP pres)	1
8,715	43.21698	1	female	0	11	492	Lung Cancer	Cancer	1	13	>$50k	0	18,964	12,439.8594	11,921.0938	12	white	14.5	18	0.794922	0.566895	1	0	0	metastatic	0.6	0.1	no dnr	11	75	16.699219	120	12	36.19531	210	2.5	1.799805	0.799927	138	7.449219	179	39	1,200	0	0	no(M2 and SIP pres)	0
8,716	59.74298	1	male	0	3	163	Lung Cancer	Cancer	2	14	$25-$50k	0	4,125	2,489.4258	1,088.78906	null	white	15.599609	2	0.746948	0.484985	1	0	0	metastatic	0.8	0.5	no dnr	3	69	21.097656	130	44	39.09375	108.875	2.599609	null	0.699951	142	7.459961	249	14	1,575	0	null	no(M2 and SIP pres)	0.494751
8,717	69.46698	0	female	0	5	796	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	4,184	2,792.2969	2,522.36914	15	white	18.597656	13	0.862915	0.773926	1	1	0	no	0.9	0.8	no dnr	5	72	9.5	79	22	36.59375	null	null	null	0.899902	140	null	113	25	null	0	0	null	0
8,718	83.25494	1	female	0	4	337	CHF	COPD/CHF/Cirrhosis	0	16	$11-$25k	0	2,127	1,396.165	1,228.50977	11	white	20.5	56	0.791992	0.665894	1	0	0	no	null	null	dnr before sadm	-1	72	null	104	40	38.09375	222.84375	3	0.599976	0.799927	134	7.469727	154	17	1,200	0	null	no(M2 and SIP pres)	0.494751
8,719	74.41199	1	male	0	9	667	CHF	COPD/CHF/Cirrhosis	4	12	null	0	5,954	4,052.7539	3,623.86914	5.5	white	21.898438	35	0.707886	0.547974	1	1	0	metastatic	null	null	dnr after sadm	1	80	4.799805	81	24	36.5	480.9375	2.099609	8.199219	1.699951	133	7.40918	127	28	1,600	1	1	no(M2 and SIP pres)	1
8,720	69.68396	1	male	1	4	4	COPD	COPD/CHF/Cirrhosis	4	12	$25-$50k	37	33,100	21,796.5625	20,146.1562	63	white	40.59375	62	0.212982	0.067993	1	1	0	no	0.5	0.5	no dnr	4	105	null	101	48	36.09375	181.46875	null	null	null	140	7.359375	null	null	48	null	null	<2 mo. follow-up	3.724609
8,721	58.85797	1	female	0	109	130	Coma	Coma	1	10	null	55	116,164	109,721.812	119,173.688	29.5	white	19.796875	23	0.511963	0.440979	12	1	0	no	0.75	0.75	no dnr	109	81	9.099609	63	24	35.89844	null	null	0.5	1	128	null	257	10	2,450	null	0	null	0
8,722	84.27698	1	male	1	5	5	COPD	COPD/CHF/Cirrhosis	3	13	under $11k	0	5,460	3,369.4941	3,020.37891	18	white	24.5	35	0.665894	0.491943	1	0	0	no	null	null	dnr before sadm	-1	60	3.699707	150	42	38.79688	108	2.599609	0.599976	0.699951	137	7.25	160	7	3,950	null	null	<2 mo. follow-up	3.415039
8,723	40.29797	1	female	0	7	251	Colon Cancer	Cancer	5	14	$11-$25k	0	5,921	3,866.3652	4,304.56641	8.5	white	21.398438	19	0.80188	0.578979	1	0	0	metastatic	0.6	0.1	no dnr	7	107	13.398438	110	40	38.69531	307.25	2.099609	1	1.399902	145	7.349609	262	46	2,875	null	null	null	2.475098
8,724	86.89899	1	male	0	7	23	CHF	COPD/CHF/Cirrhosis	7	8	null	0	5,325	3,531.0039	3,393.24805	5.5	white	19.199219	22	0.75	0.605957	1	1	0	yes	0.98	0.95	dnr after sadm	1	78	5.899414	93	16	36.29688	null	null	null	1.099854	134	null	101	23	3,425	0	0	<2 mo. follow-up	0
8,725	65.49799	1	female	0	12	174	Colon Cancer	Cancer	1	12	$25-$50k	0	16,509	10,621.1328	11,741.8984	17	white	14.099609	11	0.851929	0.671997	1	0	0	metastatic	0.9	0.5	no dnr	12	69	9.199219	69	24	35.59375	193.3125	null	0.599976	1.099854	151	7.25	97	19	null	2	1	no(M2 and SIP pres)	1
8,726	74.08899	1	female	0	13	657	COPD	COPD/CHF/Cirrhosis	3	8	null	0	13,953	8,987.8828	8,930.65625	13.5	white	20.898438	31	0.806885	0.687988	1	1	0	no	0.9	0.8	dnr after sadm	2	61	11.099609	87	24	35.79688	195.90625	null	1.299805	1.5	138	7.359375	153	29	null	2	1	SIP>=30	1
8,727	70.97894	1	male	0	5	375	Lung Cancer	Cancer	2	null	null	0	5,531	3,486.9531	3,746.03906	11	white	6	21	0.860962	0.689941	1	0	0	metastatic	0.6	0.3	no dnr	5	83	4.099609	70	20	36.19531	null	3.299805	0.399963	1	132	null	102	17	2,675	null	null	null	2.37793
8,728	73.40997	0	male	0	12	783	COPD	COPD/CHF/Cirrhosis	3	8	null	0	12,190	7,729.9258	6,668.78906	9	white	26	44	0.728882	0.575928	1	1	0	no	null	null	dnr after sadm	1	141	3.699707	89	24	36.59375	342.8125	null	0.199982	0.699951	135	7.469727	95	23	1,175	null	4	no(M2 and SIP pres)	4
8,729	65.35498	1	male	0	14	244	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	25,070	17,162.6562	17,509.5469	16.333328	white	23.398438	34	0.813965	0.751953	1	1	0	no	0.95	0.8	no dnr	14	111	9.099609	96	24	36.59375	null	2.399902	0.5	2.5	137	null	101	37	2,025	1	0	SIP>=30	0
8,730	81.18298	0	female	0	6	779	CHF	COPD/CHF/Cirrhosis	2	8	null	0	3,984	2,696.1523	2,405.09961	9	white	18	19	0.833984	0.728882	1	0	0	no	0.75	0.5	dnr before sadm	-1	62	4.699219	79	20	36.39844	null	3.799805	0.399963	0.899902	134	null	160	5	1,375	2	3	no(M2 and SIP pres)	3
8,731	74.61694	1	male	0	20	90	Lung Cancer	Cancer	1	12	$11-$25k	0	12,082	8,386.3984	9,921.57812	7	white	12.398438	21	0.770996	0.524902	1	0	0	metastatic	0.8	0.4	no dnr	20	64	21.699219	136	10	39.09375	182	null	0.699951	1.599854	165	7.489258	535	16	8,150	0	1	no(M2 and SIP pres)	1
8,732	78.85797	1	female	0	5	10	Coma	Coma	2	null	null	61	11,071	7,437.3203	9,641.11719	33	white	20.296875	21	0.370972	0.297974	1	0	0	no	null	null	dnr before sadm	-1	64	11	102	36	36.59375	204.75	null	0.899902	2	140	7.40918	91	32	2,595	null	null	<2 mo. follow-up	2.486328
8,733	54.38998	1	male	0	12	45	Lung Cancer	Cancer	2	12	under $11k	0	7,294	4,587.8359	4,631.10938	3.5	white	15.199219	20	0.763916	0.513916	1	0	0	metastatic	1	0.95	no dnr	12	70	16.296875	67	34	37.5	148	null	0.399963	0.699951	137	7.30957	157	19	1,475	0	0	<2 mo. follow-up	0
8,734	89.47797	1	female	0	9	319	CHF	COPD/CHF/Cirrhosis	6	13	null	0	5,923	3,958.7891	3,650.44922	12.5	white	22.796875	31	0.724976	0.569946	1	0	0	no	0.75	0.25	dnr after sadm	1	69	7.5	104	24	35.89844	320	null	1.399902	1.099854	138	7.5	99	19	null	null	7	adl>=4 (>=5 if sur)	7
8,735	76.74695	1	male	0	10	211	CHF	COPD/CHF/Cirrhosis	6	8	under $11k	0	6,191	4,101.8906	3,931.87891	4.5	white	16.296875	14	0.832886	0.727905	1	0	0	yes	0.7	0.5	no dnr	10	77	11.099609	77	24	36.09375	223.78125	4	0.5	1	140	7.429688	120	8	3,740	2	2	SIP>=30	2
8,736	46.702	0	male	0	6	773	Coma	Coma	1	12	$25-$50k	0	11,002	7,584.875	9,858.64844	11	white	19.296875	16	0.840942	0.80896	3	0	0	no	0.95	0.95	no dnr	6	71	6	71	24	36.39844	253.84375	null	null	0.799927	141	7.40918	120	10	1,075	0	0	no(M2 and SIP pres)	0
8,737	90.53497	0	male	0	14	774	COPD	COPD/CHF/Cirrhosis	3	5	null	0	9,899	6,333.6719	6,989.06641	7.333332	white	19.898438	32	0.705933	0.543945	1	0	0	no	0.8	0.5	dnr before sadm	0	121	16.898438	112	8	38.89844	255	3.899902	0.799927	1.099854	140	7.429688	226	12	2,905	null	1	no(M2 and SIP pres)	1
8,738	80.745	1	male	0	4	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	6	null	37	8,599	5,789.1133	6,502.00781	31	white	31	40	0.417969	0.29895	1	0	0	no	0.25	0.1	dnr after sadm	1	43	21.699219	104	36	35.59375	168.3125	2.699707	0.399963	0.5	143	7.399414	149	18	805	null	5	<2 mo. follow-up	5
8,739	48.47897	0	male	0	53	772	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	9	99,065	66,641.9375	80,853.75	39.25	white	27.898438	40	0.783936	0.713989	1	0	0	no	0.75	0.75	no dnr	53	107	41.898438	112	30	35.79688	91.65625	2.599609	0.799927	6.599609	129	7.439453	202	40	0	null	0	adl>=4 (>=5 if sur)	0
8,740	57.21597	0	male	0	11	770	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$11-$25k	0	9,600	6,362.043	7,529.85938	16.5	other	20.898438	32	0.865967	0.819946	1	1	0	no	0.5	0.4	dnr after sadm	3	57	8.298828	60	26	36.09375	304.75	null	null	1.099854	135	7.399414	212	16	2,485	null	7	adl>=4 (>=5 if sur)	7
8,741	70.90796	1	male	0	4	19	Lung Cancer	Cancer	2	12	under $11k	0	3,590	2,661.1875	2,430.67969	4	white	13.898438	21	0.75293	0.494995	1	0	0	metastatic	0.5	0.2	dnr after sadm	1	55	16.699219	142	22	39.69531	201.65625	1.699951	2.299805	3	137	7.199219	388	31	null	null	null	<2 mo. follow-up	2.099609
8,742	78.245	1	male	0	35	50	Coma	Coma	3	8	null	61	43,459	28,174.9375	31,811.0781	15	white	16.796875	29	0.393982	0.319946	1	0	0	yes	0.7	0.6	dnr after sadm	9	36	42.296875	128	54	38.39844	252.375	2.299805	1.099854	8.599609	129	7.399414	215	120	0	null	1	<2 mo. follow-up	1
8,743	88.375	0	female	0	11	763	ARF/MOSF w/Sepsis	ARF/MOSF	0	5	under $11k	0	10,371	7,066.0859	7,182.92969	17	white	22.597656	44	0.740967	0.659912	1	0	0	no	0.8	0.75	dnr after sadm	1	63	null	114	38	38.29688	174.28125	1.899902	1.299805	1.399902	142	7.509766	143	49	1,925	null	1	no(M2 and SIP pres)	1
8,744	50.62598	1	female	0	5	422	Colon Cancer	Cancer	2	16	>$50k	0	3,827	2,371.9648	1,742.90918	7	white	14.599609	9	0.86792	0.704956	1	0	0	metastatic	0.9	0.5	no dnr	5	141	26.699219	132	24	36.59375	106.65625	null	null	0.899902	133	7.40918	178	20	4,100	0	0	no(M2 and SIP pres)	0
8,745	66.08099	1	male	0	5	509	Lung Cancer	Cancer	3	12	>$50k	0	5,742	3,662.0156	2,800.14844	14	white	18.199219	15	0.681885	0.386963	1	0	0	metastatic	0.8	0.6	no dnr	5	79	4.799805	65	18	35.79688	null	4	0.399963	1	138	null	95	16	null	null	null	no(M2 and SIP pres)	2.419434
8,746	65.11395	1	male	0	7	77	CHF	COPD/CHF/Cirrhosis	4	12	null	0	7,216	4,896.9844	4,392.24609	12	white	31.597656	57	0.682983	0.513916	1	0	0	no	0.7	0.5	no dnr	7	101	10.699219	60	24	35.39844	208	null	1.299805	1.5	135	7.419922	176	43	1,725	1	1	null	1
8,747	72.534	1	male	0	13	146	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	$11-$25k	37	26,337	17,738.7656	18,998.2188	34.5	white	19.898438	19	0.707886	0.619995	3	0	0	no	0.8	0.8	no dnr	13	72	7.099609	61	20	36.19531	null	3.299805	0.299988	1.199951	142	null	76	18	1,775	null	1	no(M2 and SIP pres)	1
8,748	76.26294	0	female	0	30	755	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	0	101,645	65,776.875	74,070	27.5	white	21.296875	24	0.733887	0.650879	32	0	0	no	0.75	0.5	no dnr	30	83	6.299805	89	18	36.79688	null	null	null	0.799927	134	null	98	12	null	null	null	null	1.938965
8,749	79.37299	1	male	0	11	290	CHF	COPD/CHF/Cirrhosis	2	8	null	0	7,302	4,651.1211	4,865.4375	10	white	22.199219	31	0.782959	0.652954	1	0	0	no	0.8	0.7	no dnr	11	117	15.599609	79	20	36	null	3.599609	0.299988	1.099854	134	null	141	11	null	0	0	no(M2 and SIP pres)	0
8,750	78.42596	0	female	0	11	750	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	19,552	13,048.4062	12,614.1641	20	white	24.296875	38	0.705933	0.616943	5	0	0	no	0.25	0.1	dnr after sadm	2	64	3	40	12	31.69922	null	3	1.899902	1.399902	142	null	98	12	2,390	0	1	no(M2 and SIP pres)	1
8,751	69.56598	1	male	0	19	276	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	21,123	15,517.9609	14,915.375	12.666664	white	22.796875	57	0.80896	0.744995	1	0	0	no	0.5	0.3	no dnr	19	73	31.796875	122	44	36.69531	145	1.799805	3	2.699707	128	7.449219	95	73	1,098	1	0	no(M2 and SIP pres)	0
8,752	71.20099	1	male	1	16	16	Coma	Coma	2	12	null	89	23,547	16,675.1406	17,210.0469	29	white	28.5	66	0.098999	0.058998	1	0	0	no	null	null	dnr after sadm	3	105	8	98	16	36.19531	null	4.099609	0.199982	1.299805	133	null	104	17	3,225	null	0	<2 mo. follow-up	0
8,753	50.93799	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	47,782	31,594.3594	31,824.6562	49	white	26.199219	63	0.809937	0.745972	2	0	0	no	0.8	0.7	no dnr	7	60	10.599609	131	28	36.59375	276.875	null	0.699951	2	133	7.479492	83	49	1,200	null	null	<2 mo. follow-up	2.028809
8,754	54.95398	1	male	1	36	36	MOSF w/Malig	ARF/MOSF	3	12	under $11k	0	188,415	120,854.812	145,093.125	34.75	white	36.5	75	0.259949	0.153992	26	0	0	yes	0.8	0.6	dnr after sadm	35	61	3.399902	67	28	34.79688	null	2.399902	11.5	1.099854	139	null	206	66	1,750	null	0	<2 mo. follow-up	0
8,755	92.68195	0	male	0	5	748	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	3,435	2,327.6621	2,424.68945	11	white	20.398438	31	0.75293	0.609985	1	0	0	no	0.9	0.6	no dnr	5	68	16.097656	107	24	36.39844	165	4.099609	0.199982	1.199951	132	7.339844	446	42	3,150	0	0	no(M2 and SIP pres)	0
8,756	52.38599	1	male	0	4	120	Lung Cancer	Cancer	2	12	$25-$50k	0	3,526	2,257.0606	2,564.62891	10	white	1.199951	19	0.918945	0.809937	1	0	0	metastatic	0.9	0.75	no dnr	4	69	12.199219	64	35	35.69531	133.84375	2.699707	0.799927	0.899902	138	7.449219	168	24	1,375	null	0	no(M2 and SIP pres)	0
8,757	62.004	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	null	44	68,056	47,110.8438	48,286.9062	40	white	37	67	0.227997	0.128998	12	0	0	no	0.1	0.1	no dnr	5	134	10.199219	107	20	36.19531	357.125	null	null	1.599854	131	7.389648	133	25	1,775	null	0	<2 mo. follow-up	0
8,758	59.67697	1	male	0	12	96	Lung Cancer	Cancer	2	11	$11-$25k	0	16,618	10,802.1797	11,391.1328	9.5	white	25.296875	30	0.524902	0.201996	1	0	0	metastatic	0.95	0.5	dnr after sadm	10	80	20.097656	81	24	36	278.25	4.299805	0.5	0.799927	133	7.379883	136	11	null	0	0	SIP>=30	0
8,759	45.38498	0	male	0	59	743	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	0	129,834	null	null	35.75	white	29.398438	34	0.771973	0.698975	3	0	1	no	0.8	0.8	no dnr	59	63	5.199219	69	24	35.79688	185	null	null	1.099854	145	7.359375	87	25	1,425	null	null	no(M2 and SIP pres)	4.081055
8,760	68.81598	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	0	12,606	8,449.125	9,210.875	24	white	36.296875	68	0.451965	0.332947	1	0	0	yes	null	null	no dnr	4	109	8.199219	50	24	36.29688	null	null	null	1.199951	136	null	97	23	4,050	null	null	<2 mo. follow-up	2.492676
8,761	78.85596	0	male	0	7	744	COPD	COPD/CHF/Cirrhosis	0	12	null	0	3,988	2,595.7773	2,477.75	2.5	white	13.298828	39	0.871948	0.787964	1	0	0	no	null	null	no dnr	7	72	8.398438	74	20	36.59375	null	3.799805	0.399963	1	140	null	76	9	8,600	null	null	null	2.612305
8,762	41.83197	0	female	0	13	742	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	28,393	18,363.4062	35,137.625	28	white	29.699219	44	0.779907	0.708984	3	0	0	no	0.5	0.5	no dnr	13	57	10.398438	167	24	35.89844	null	null	null	1	137	null	91	21	null	null	0	no(M2 and SIP pres)	0
8,763	70.97095	1	male	0	11	76	Lung Cancer	Cancer	3	12	$25-$50k	0	9,176	6,019.9141	6,357.51953	8	white	11.398438	31	0.792969	0.56189	1	0	0	metastatic	null	null	no dnr	11	74	13.199219	79	26	36.19531	183.3125	3.199707	0.399963	0.599976	141	7.439453	207	4	2,700	0	0	null	0
8,764	56.09	1	male	0	8	169	Cirrhosis	COPD/CHF/Cirrhosis	5	12	$25-$50k	0	11,949	8,494.4922	8,861.69531	19.5	white	26.296875	44	0.642944	0.461975	1	1	0	yes	0.3	0.2	no dnr	8	90	13.599609	69	28	36.19531	276	null	0.599976	0.799927	141	7.369141	242	20	3,300	0	0	no(M2 and SIP pres)	0
8,765	77.03796	0	female	0	5	723	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	3,384	2,219.3242	2,252.79883	8	white	16.898438	11	0.859985	0.767944	1	0	0	no	0.7	0.6	dnr after sadm	1	71	6.799805	101	28	35.79688	446.625	3.799805	0.299988	1.099854	136	7.319336	117	26	875	5	3	no(M2 and SIP pres)	3
8,766	71.28796	1	male	0	7	26	Lung Cancer	Cancer	2	12	null	0	4,495	2,965.0957	2,815.22852	6	white	25.296875	27	0.485962	0.166992	1	0	0	metastatic	0.25	0.1	dnr after sadm	1	101	9.898438	66	20	35.79688	347.5625	2.699707	0.199982	0.599976	128	7.459961	120	14	3,400	4	2	<2 mo. follow-up	2
8,767	56.33899	1	male	1	5	5	Coma	Coma	1	8	null	55	16,220	11,137.3359	12,067.9062	47	white	24.398438	36	0.453979	0.379944	4	1	0	no	0.5	0.5	dnr after sadm	5	100	31.398438	104	24	36.19531	319	null	null	0.899902	137	7.429688	168	21	3,800	null	null	<2 mo. follow-up	2.056152
8,768	31.22198	1	male	0	80	173	CHF	COPD/CHF/Cirrhosis	4	16	>$50k	0	100,714	64,004.9688	67,753.3125	15.25	white	24.597656	23	0.87793	0.796997	1	1	0	yes	0.5	0.25	no dnr	80	61	10.798828	58	15	36.79688	91.82812	null	1	0.899902	139	7.419922	163	11	2,685	0	0	no(M2 and SIP pres)	0
8,769	75.22198	1	female	0	22	518	CHF	COPD/CHF/Cirrhosis	3	8	null	0	16,569	10,865.5234	10,600.4453	12.666664	white	17.699219	34	0.855957	0.762939	1	1	0	no	null	null	no dnr	22	61	7.299805	100	24	39.39844	136	2	0.799927	10.099609	135	7.459961	188	72	null	null	null	null	2.820313
8,770	18.18999	0	female	0	21	718	Coma	Coma	0	11	null	94	49,598	32,209.9375	39,172.5	26	white	34	39	0.31897	0.246979	10	0	0	no	0.49	0.49	no dnr	21	117	16.699219	76	32	36	188	null	0.299988	0.799927	139	7.429688	183	16	1,625	null	0	no(M2 and SIP pres)	0
8,771	91.28796	1	female	1	5	5	CHF	COPD/CHF/Cirrhosis	3	10	$11-$25k	0	3,350	2,227.3711	2,336.53906	14	white	20.699219	39	0.754883	0.612915	1	0	0	no	null	null	dnr before sadm	-1	108	0.699951	156	22	36.69531	null	2.099609	1.299805	0.699951	132	null	122	8	2,750	null	null	<2 mo. follow-up	3.164551
8,772	33.09497	0	male	0	5	717	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	9,241	6,637.9531	7,612.96875	16	white	20.296875	18	0.906982	0.872925	3	0	0	no	0.95	0.95	no dnr	5	113	10.199219	59	28	38.79688	200	null	null	1.599854	137	7.479492	121	17	2,440	null	null	null	2.663574
8,773	30.69099	0	female	0	10	717	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	22,970	14,684.5781	16,134.2891	22	white	23.597656	12	0.885986	0.844971	3	0	0	no	0.95	0.95	no dnr	10	76	18.398438	72	26	36.39844	262.5	3.399902	0.5	0.699951	136	7.389648	102	9	2,700	1	0	null	0
8,774	82.60596	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	50,759	33,172.375	35,029.3438	47	white	34.5	58	0.359985	0.242981	30	0	0	no	0.2	0.2	dnr after sadm	5	105	9.099609	140	40	38.29688	194.28125	null	null	1.399902	140	7.339844	249	24	2,175	null	2	<2 mo. follow-up	2
8,775	69.90796	1	male	0	11	121	Lung Cancer	Cancer	1	null	null	0	14,305	9,534.0078	9,594.52344	8	white	15.398438	12	0.728882	0.45697	1	0	0	metastatic	0.5	0.3	dnr after sadm	4	65	8.298828	85	28	36.19531	320	null	null	1.399902	128	7.419922	140	58	null	2	0	no(M2 and SIP pres)	0
8,776	69.58795	0	female	0	32	712	CHF	COPD/CHF/Cirrhosis	4	12	null	0	29,039	19,057.5938	17,706.5156	10.5	white	11.398438	19	0.920898	0.866943	1	1	0	no	null	null	no dnr	32	77	11.199219	80	29	39	202.5	2.099609	0.399963	0.699951	129	7.469727	99	11	2,440	2	0	SIP>=30	0
8,777	68.19397	1	male	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	64,704	42,494.7812	49,044.5312	38	white	31.796875	55	0.651978	0.552979	1	0	0	no	0.3	0.25	no dnr	20	76	24.796875	72	28	39.09375	413.3125	2.199707	0.399963	1.199951	139	7.469727	209	36	2,250	null	6	<2 mo. follow-up	6
8,778	64.93396	1	male	0	4	7	Coma	Coma	1	10	null	100	7,978	null	null	46	white	24.097656	48	0.131989	0.084	1	0	0	yes	0.25	0.2	no dnr	4	50	18.898438	118	30	40	90	3	1.099854	1.5	136	7.389648	137	34	910	null	0	<2 mo. follow-up	0
8,779	81.88599	0	male	0	7	710	COPD	COPD/CHF/Cirrhosis	2	null	null	0	5,530	3,641.418	5,381.83984	4.5	white	16.796875	13	0.817993	0.704956	1	0	0	no	0.6	0.8	no dnr	7	115	7.899414	93	20	36.89844	null	3.599609	0.299988	1.299805	136	null	201	14	null	null	null	null	3.469727
8,780	64.24396	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	41	22,241	15,178.0938	17,272.4219	41	white	35	58	0.33197	0.21698	4	0	0	no	0.5	0.3	dnr after sadm	3	105	null	71	24	35.79688	280.9375	null	null	0.699951	137	7.379883	96	9	975	null	0	<2 mo. follow-up	0
8,781	51.01199	0	female	0	6	706	CHF	COPD/CHF/Cirrhosis	3	12	$25-$50k	0	5,990	4,180.5078	4,135.09766	16	white	15.398438	34	0.927979	0.876953	1	1	0	no	0.95	0.9	no dnr	6	60	10.5	148	32	36.39844	155	2.599609	0.399963	0.699951	141	7.389648	130	13	1,200	2	3	SIP>=30	3
8,782	78.32196	1	male	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	under $11k	100	110,595	73,481.75	78,108.0625	46.5	white	25.398438	37	0.190979	0.100998	7	0	0	no	0.6	0.5	dnr after sadm	32	108	16.699219	126	46	39.39844	182.5	null	0.799927	1.399902	143	7.389648	204	21	2,100	null	2	<2 mo. follow-up	2
8,783	63.04999	1	female	0	18	124	Colon Cancer	Cancer	1	13	null	0	21,542	13,636.2188	13,912.6094	15	white	8.5	15	0.905884	0.781982	1	0	0	metastatic	0.95	0.9	no dnr	18	52	22.296875	76	6	36.19531	420	2.099609	0.699951	2.799805	147	7.369141	221	81	2,725	0	0	no(M2 and SIP pres)	0
8,784	66.95099	1	female	0	36	154	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	$25-$50k	41	125,149	84,051.8125	96,757	35	white	15.099609	38	0.760986	0.68396	21	1	0	no	0.75	0.6	dnr after sadm	2	101	12	66	20	36.39844	352.375	null	1.5	1.699951	138	7.479492	110	31	null	null	7	adl>=4 (>=5 if sur)	7
8,785	73.04895	0	female	0	9	699	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	9	7,873	5,457.4727	5,522.97656	12	white	16.296875	13	0.850952	0.754883	1	1	0	no	0.9	0.8	no dnr	9	103	9.699219	74	22	36.79688	247.59375	2.699707	0.299988	0.799927	143	7.279297	158	8	null	0	1	no(M2 and SIP pres)	1
8,786	83.77295	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	4	null	$25-$50k	0	93,380	63,700.25	67,331.5625	47	white	58.398438	103	0.001	0	19	1	0	no	0	0	no dnr	3	109	8.298828	114	12	37.79688	null	1.799805	4.699219	0.599976	139	null	132	7	965	null	null	<2 mo. follow-up	2.87207
8,787	22.146	0	male	0	11	698	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	under $11k	0	29,891	19,014	21,844.5	23	white	16.398438	17	0.914917	0.883911	16	0	0	yes	0.7	0.7	no dnr	11	83	10.898438	76	18	36.79688	null	null	0.399963	1.099854	140	null	96	9	null	0	0	no(M2 and SIP pres)	0
8,788	68.06	1	female	0	3	432	Lung Cancer	Cancer	2	12	$11-$25k	0	4,051	2,550	1,565.18945	null	white	11.298828	19	0.799927	0.574951	1	0	0	metastatic	0.6	0.4	no dnr	3	51	12.398438	45	24	36.69531	217.375	3.599609	0.399963	1.299805	130	7.399414	211	23	1,700	null	0	no(M2 and SIP pres)	0
8,789	69.91895	0	male	0	6	697	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	4,386	2,976.1621	2,650.1582	14	white	19.097656	15	0.85791	0.764893	1	0	0	no	1	0.9	no dnr	6	72	3.899902	42	20	35.79688	null	4	0.399963	0.799927	138	null	144	12	3,250	0	null	no(M2 and SIP pres)	0.494751
8,790	78.21497	1	female	0	10	679	COPD	COPD/CHF/Cirrhosis	0	12	under $11k	0	6,278	4,128.7109	4,527.03906	8.5	white	20	31	0.794922	0.669922	1	0	0	no	0.8	0.6	dnr after sadm	1	84	null	67	20	36.19531	null	null	null	1.099854	136	null	110	13	null	5	3	SIP>=30	3
8,791	56.64899	1	male	1	9	9	MOSF w/Malig	ARF/MOSF	1	13	$25-$50k	9	64,165	39,395.8125	41,394.1875	32.5	white	31.699219	44	0.359985	0.242981	18	0	0	yes	0.8	0.7	no dnr	9	96	9.5	107	24	36.09375	280.9375	3.699707	1.399902	1.299805	142	7.479492	117	18	3,225	null	0	<2 mo. follow-up	0
8,792	74.85297	0	male	0	26	694	Coma	Coma	2	8	$25-$50k	100	26,893	18,100	16,823.4062	16.75	white	22.296875	39	0.161987	0.107986	1	0	0	no	0.04	0.04	no dnr	26	59	5.899414	76	30	35.79688	null	4.099609	2	2.699707	138	null	98	58	1,125	null	0	null	0
8,793	70.86096	1	female	0	9	370	CHF	COPD/CHF/Cirrhosis	3	11	under $11k	0	8,175	5,472.7891	4,906.45703	8.5	white	17.699219	35	0.868896	0.782959	1	1	0	no	0.7	0.5	no dnr	9	127	6.099609	65	24	35.69531	419	null	0.199982	2.899902	140	7.429688	120	63	2,050	1	2	no(M2 and SIP pres)	2
8,794	84.85394	0	male	0	14	691	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	null	0	22,306	14,743.6094	14,665.6172	16.333328	white	31	37	0.572998	0.462952	1	0	0	no	0.8	0.8	no dnr	14	46	19.296875	105	10	39.39844	133.84375	3.199707	0.5	2.299805	133	7.339844	301	24	353	null	0	null	0
8,795	86.14899	1	male	1	10	10	Coma	Coma	1	10	null	100	15,476	9,943.0547	9,845.78906	27.5	white	22.398438	39	0.079987	0.044998	1	0	0	no	0.3	0.3	dnr after sadm	9	64	6.799805	114	24	36.19531	400	3.199707	0.899902	1.099854	138	7.509766	158	21	2,150	null	1	<2 mo. follow-up	1
8,796	91.33197	0	male	0	12	686	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	37	22,799	15,125.9453	15,507.0625	18.5	white	32.296875	52	0.305969	0.19397	1	0	0	no	null	null	dnr before sadm	-1	107	18.5	70	10	35.89844	207.5	4.199219	0.599976	0.699951	138	7.489258	254	23	1,790	null	0	SIP>=30	0
8,797	58.80099	0	female	0	69	686	COPD	COPD/CHF/Cirrhosis	7	11	null	0	140,005	99,652.9375	97,953.9375	40	white	31.398438	52	0.695923	0.530884	5	1	0	no	0.3	0.3	no dnr	69	72	11.199219	74	28	36.39844	106.65625	null	0.699951	1.099854	135	7.30957	178	36	null	null	6	SIP>=30	6
8,798	68.45398	1	male	0	65	168	MOSF w/Malig	ARF/MOSF	2	12	$11-$25k	26	94,981	58,759.7812	59,123.8438	25.75	white	32	50	0.225983	0.127991	3	0	0	metastatic	null	null	no dnr	65	76	20.398438	135	16	36.69531	null	null	null	1	138	null	90	10	2,600	0	0	SIP>=30	0
8,799	73.396	1	female	0	8	377	CHF	COPD/CHF/Cirrhosis	2	12	null	0	6,134	4,247.75	3,538.66992	4.5	white	17.597656	26	0.862915	0.773926	1	0	0	no	null	null	dnr after sadm	2	101	10.398438	96	24	36.29688	null	3.599609	0.699951	1.699951	135	null	260	17	1,900	2	0	no(M2 and SIP pres)	0
8,800	41.88898	1	female	0	5	504	Lung Cancer	Cancer	1	13	null	0	7,325	5,001.2109	4,844.12891	4	white	16.5	11	0.767944	0.518921	1	0	0	metastatic	null	null	no dnr	5	70	8.5	62	20	37.69531	null	null	null	0.899902	138	null	84	11	null	0	1	no(M2 and SIP pres)	1